| JYHB2100235 | 恩扎卢胺软胶囊 | enzalutamide | Soft capsules | Chemical Drugs(5.1) | Supplementary Application | 2021-04-10 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Completed-Pending Issued | 2021-07-05 | view |
| JYHZ2100060 | 盐酸奥洛他定片 | olopatadine hydrochloride | Tablet | Chemical Drugs | License Renew | 2021-03-20 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Completed-Pending Withdrawn | 2021-07-05 | view |
| JYHZ2100059 | 盐酸奥洛他定片 | olopatadine hydrochloride | Tablet | Chemical Drugs | License Renew | 2021-03-20 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Completed-Pending Withdrawn | 2021-07-05 | view |
| JYHB2100160 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2021-02-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2022-01-27 | view |
| JYHB2100159 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2021-02-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2022-01-27 | view |
| JYHB2100158 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2021-02-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2022-01-27 | view |
| JYHB2100157 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2021-02-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2022-01-27 | view |
| JXHS2000181 | 他克莫司胶囊 | tacrolimus | Capsule | Chemical Drugs(5.1) | Import Drug Application | 2020-12-16 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-12-15 | view |
| JXSL2000222 | 注射用enfortumab vedotin | enfortumab vedotin | Lyophilized | Biological Products(2.2) | Import Drug Application | 2020-12-14 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-12-10 | view |
| JXSL2000221 | 注射用enfortumab vedotin | enfortumab vedotin | Lyophilized | Biological Products(2.2) | Import Drug Application | 2020-12-14 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-12-10 | view |
| JYHF2000097 | 他克莫司颗粒 | tacrolimus | Granule | Chemical Drugs(5.1) | Supplementary Application | 2020-11-02 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Filed | 2020-11-17 | view |
| JYHF2000096 | 他克莫司颗粒 | tacrolimus | Granule | Chemical Drugs(5.1) | Supplementary Application | 2020-11-02 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Filed | 2020-11-17 | view |
| JYHZ2000231 | 注射用米卡芬净钠 | micafungin sodium | Lyophilized | Chemical Drugs | License Renew | 2020-10-29 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-10-29 | view |
| JYHZ2000230 | 注射用米卡芬净钠 | micafungin sodium | Lyophilized | Chemical Drugs | License Renew | 2020-10-29 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-10-28 | view |
| JXSL2000174 | 注射用enfortumab vedotin | enfortumab vedotin | Lyophilized | Biological Products(3.1) | Import Drug Application | 2020-10-10 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-10-09 | view |
| JXSL2000173 | 注射用enfortumab vedotin | enfortumab vedotin | Lyophilized | Biological Products(3.1) | Import Drug Application | 2020-10-10 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-10-09 | view |
| JYHB2001872 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2020-09-25 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Filed | 2020-10-16 | view |
| JYHB2001873 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2020-09-25 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | Filed | 2020-10-16 | view |
| JYHB2001858 | 他克莫司胶囊 | tacrolimus | Capsule | Chemical Drugs | Supplementary Application | 2020-09-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-09-23 | view |
| JYHB2001862 | 注射用米卡芬净钠 | micafungin sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2020-09-24 | 安斯泰来制药（中国）有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-09-23 | view |
